Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor

por Hu, Zexi, Hu, Yong, Liu, Xicheng, Xi, Rongwen, Zhang, Aiqun, Liu, Deruo, Xie, Qiang, Chen, Liang
Publicado 2015

Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor

por Hu, Zexi, Hu, Yong, Liu, Xicheng, Xi, Rongwen, Zhang, Aiqun, Liu, Deruo, Xie, Qiang, Chen, Liang
Publicado 2018

Phosphorylation of Mutationally Introduced Tyrosine in the Activation Loop of HER2 Confers Gain-of-Function Activity

por Hu, Zexi, Wan, Xiaobo, Hao, Rui, Zhang, Heng, Li, Li, Li, Lin, Xie, Qiang, Wang, Peng, Gao, Yibo, Chen, She, Wei, Min, Luan, Zhidong, Zhang, Aiqun, Huang, Niu, Chen, Liang
Publicado 2015

Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition

por Xing, Jun, Bhuria, Vikas, Bui, Khac Cuong, Nguyen, Mai Ly Thi, Hu, Zexi, Hsieh, Chih-Jen, Wittstein, Kathrin, Stadler, Marc, Wilkens, Ludwig, Li, Jun, Kalesse, Markus, Bozko, Przemyslaw, Plentz, Ruben R.
Publicado 2020